Can Kratom (Mitragyna speciosa) use lead to withdrawal symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kratom Withdrawal Syndrome: Clinical Features and Management

Yes, Kratom (Mitragyna speciosa) use can lead to significant withdrawal symptoms upon discontinuation, particularly in regular users. Research demonstrates that Kratom dependence and withdrawal are real clinical phenomena that should be recognized and managed appropriately 1, 2.

Pharmacology and Mechanism

Kratom contains over 40 alkaloids, with mitragynine and 7-hydroxymitragynine being the primary psychoactive compounds. These alkaloids act as:

  • Partial mu-opioid receptor agonists
  • Also affect adrenergic, serotonergic, and dopaminergic pathways 3
  • Function as atypical opioids with narcotic-like properties

Withdrawal Symptoms

Regular Kratom users experience both physical and psychological withdrawal symptoms upon cessation:

Physical Withdrawal Symptoms:

  • Muscle spasms and pain
  • Sleeping difficulty
  • Watery eyes/nose
  • Hot flashes and fever
  • Decreased appetite
  • Diarrhea
  • Tremors
  • Sweating
  • Yawning
  • Joint pain 4, 2

Psychological Withdrawal Symptoms:

  • Restlessness
  • Tension and anxiety
  • Irritability
  • Anger
  • Sadness
  • Nervousness
  • Craving for Kratom 4, 2

Risk Factors for Severe Withdrawal

The severity of Kratom withdrawal is dose-dependent. Users who consume ≥3 glasses of Kratom per day have higher odds of:

  • Developing severe Kratom dependence
  • Experiencing more intense withdrawal symptoms
  • Having difficulty controlling Kratom cravings 2

Onset and Duration of Withdrawal

Similar to opioid withdrawal, Kratom withdrawal symptoms typically:

  • Begin within 12-24 hours after the last use
  • Peak around 2-3 days
  • May persist for 5-7 days 5, 4

Clinical Assessment

Assessment should include:

  • Quantity and frequency of Kratom use
  • Duration of regular use
  • Presence of polysubstance use (common in Kratom users)
  • Previous withdrawal experiences
  • Underlying medical and psychiatric conditions

Management Approaches

Detoxification Options:

  1. Buprenorphine-naloxone (Suboxone):

    • Most promising treatment for detoxification
    • Effective for maintenance replacement therapy 4
  2. Alternative detoxification regimens:

    • Dihydrocodeine and lofexidine combination has shown effectiveness 6
    • Clonidine (intravenous) for inpatient detoxification 4
  3. Gradual tapering:

    • Preferable to abrupt discontinuation
    • Significantly reduces severity of withdrawal symptoms 5

Supportive Care:

  • Hydration and nutrition support
  • Symptomatic treatment for specific withdrawal symptoms
  • Monitoring for complications

Special Considerations

  1. Polysubstance use: Many Kratom users also use other substances, which can complicate withdrawal management 3

  2. Underlying conditions: Kratom is often used to self-medicate pain, psychiatric symptoms, or other substance use disorders 1

  3. Potential for hepatotoxicity: Monitor liver function during withdrawal period 3

  4. Risk of seizures: Although rare, seizures have been reported with Kratom use and withdrawal 3

Long-term Considerations

  • Physical dependence on Kratom develops with regular use, similar to opioids 7
  • Withdrawal symptoms reflect functional changes in brain circuits involved with reward, conditioning, and stress reactivity 7
  • Long-term management should address underlying reasons for Kratom use

Kratom withdrawal follows patterns similar to opioid withdrawal but is generally considered less severe than withdrawal from traditional opioids. Nevertheless, it requires appropriate clinical attention and management to minimize patient discomfort and prevent relapse.

References

Guideline

Substance Withdrawal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.